Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts. Tabb DL, Wang X, Carr SA, Clauser KR, Mertins P, Chambers MC, Holman JD, Wang J, Zhang B, Zimmerman LJ, Chen X, Gunawardena HP, Davies SR, Ellis MJ, Li S, Townsend RR, Boja ES, Ketchum KA, Kinsinger CR, Mesri M, Rodriguez H, Liu T, Kim S, McDermott JE, Payne SH, Petyuk VA, Rodland KD, Smith RD, Yang F, Chan DW, Zhang B, Zhang H, Zhang Z, Zhou JY, Liebler DC (2016) J Proteome Res 15(3): 691-706
    › Primary publication · 26653538 (PubMed) · PMC4779376 (PubMed Central)
  2. Quantitative Profiling of Protein Tyrosine Kinases in Human Cancer Cell Lines by Multiplexed Parallel Reaction Monitoring Assays. Kim HJ, Lin D, Lee HJ, Li M, Liebler DC (2016) Mol Cell Proteomics 15(2): 682-91
    › Primary publication · 26631510 (PubMed) · PMC4739681 (PubMed Central)
  3. Proteomic analysis of colon and rectal carcinoma using standard and customized databases. Slebos RJ, Wang X, Wang X, Wang X, Zhang B, Tabb DL, Liebler DC (2015) Sci Data : 150022
    › Primary publication · 26110064 (PubMed) · PMC4477697 (PubMed Central)
  4. Global, in situ, site-specific analysis of protein S-sulfenylation. Yang J, Gupta V, Tallman KA, Porter NA, Carroll KS, Liebler DC (2015) Nat Protoc 10(7): 1022-37
    › Primary publication · 26086405 (PubMed) · PMC4608369 (PubMed Central)
  5. Phosphotyrosine signaling analysis in human tumors is confounded by systemic ischemia-driven artifacts and intra-specimen heterogeneity. Gajadhar AS, Johnson H, Slebos RJ, Shaddox K, Wiles K, Washington MK, Herline AJ, Levine DA, Liebler DC, White FM, Clinical Proteomic Tumor Analysis Consortium (2015) Cancer Res 75(7): 1495-503
    › Primary publication · 25670172 (PubMed) · PMC4383696 (PubMed Central)
  6. Quantitative chemoproteomics for site-specific analysis of protein alkylation by 4-hydroxy-2-nonenal in cells. Yang J, Tallman KA, Porter NA, Liebler DC (2015) Anal Chem 87(5): 2535-41
    › Primary publication · 25654326 (PubMed) · PMC4350606 (PubMed Central)
  7. CHIP Is an Essential Determinant of Neuronal Mitochondrial Stress Signaling. Palubinsky AM, Stankowski JN, Kale AC, Codreanu SG, Singer RJ, Liebler DC, Stanwood GD, McLaughlin B (2015) Antioxid Redox Signal 23(6): 535-49
    › Primary publication · 25602369 (PubMed) · PMC4544748 (PubMed Central)
  8. Site-specific mapping and quantification of protein S-sulphenylation in cells. Yang J, Gupta V, Carroll KS, Liebler DC (2014) Nat Commun : 4776
    › Primary publication · 25175731 (PubMed) · PMC4167403 (PubMed Central)
  9. Proteogenomic characterization of human colon and rectal cancer. Zhang B, Wang J, Wang X, Zhu J, Liu Q, Shi Z, Chambers MC, Zimmerman LJ, Shaddox KF, Kim S, Davies SR, Wang S, Wang P, Kinsinger CR, Rivers RC, Rodriguez H, Townsend RR, Ellis MJ, Carr SA, Tabb DL, Coffey RJ, Slebos RJ, Liebler DC, NCI CPTAC (2014) Nature 513(7518): 382-7
    › Primary publication · 25043054 (PubMed) · PMC4249766 (PubMed Central)
  10. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mertins P, Yang F, Liu T, Mani DR, Petyuk VA, Gillette MA, Clauser KR, Qiao JW, Gritsenko MA, Moore RJ, Levine DA, Townsend R, Erdmann-Gilmore P, Snider JE, Davies SR, Ruggles KV, Fenyo D, Kitchens RT, Li S, Olvera N, Dao F, Rodriguez H, Chan DW, Liebler D, White F, Rodland KD, Mills GB, Smith RD, Paulovich AG, Ellis M, Carr SA (2014) Mol Cell Proteomics 13(7): 1690-704
    › Primary publication · 24719451 (PubMed) · PMC4083109 (PubMed Central)
  11. Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer. Udyavar AR, Hoeksema MD, Clark JE, Zou Y, Tang Z, Li Z, Li M, Chen H, Statnikov A, Shyr Y, Liebler DC, Field J, Eisenberg R, Estrada L, Massion PP, Quaranta V (2013) BMC Syst Biol : S1
    › Primary publication · 24564859 (PubMed) · PMC4029366 (PubMed Central)
  12. Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Carr SA, Abbatiello SE, Ackermann BL, Borchers C, Domon B, Deutsch EW, Grant RP, Hoofnagle AN, Hüttenhain R, Koomen JM, Liebler DC, Liu T, MacLean B, Mani DR, Mansfield E, Neubert H, Paulovich AG, Reiter L, Vitek O, Aebersold R, Anderson L, Bethem R, Blonder J, Boja E, Botelho J, Boyne M, Bradshaw RA, Burlingame AL, Chan D, Keshishian H, Kuhn E, Kinsinger C, Lee JS, Lee SW, Moritz R, Oses-Prieto J, Rifai N, Ritchie J, Rodriguez H, Srinivas PR, Townsend RR, Van Eyk J, Whiteley G, Wiita A, Weintraub S (2014) Mol Cell Proteomics 13(3): 907-17
    › Primary publication · 24443746 (PubMed) · PMC3945918 (PubMed Central)
  13. Alkylation damage by lipid electrophiles targets functional protein systems. Codreanu SG, Ullery JC, Zhu J, Tallman KA, Beavers WN, Porter NA, Marnett LJ, Zhang B, Liebler DC (2014) Mol Cell Proteomics 13(3): 849-59
    › Primary publication · 24429493 (PubMed) · PMC3945913 (PubMed Central)
  14. Amended safety assessment of formaldehyde and methylene glycol as used in cosmetics. Boyer IJ, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2013) Int J Toxicol 32(6 Suppl): 5S-32S
    › Primary publication · 24335968 (PubMed)
  15. Safety assessment of α-amino acids as used in cosmetics. Burnett CL, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2013) Int J Toxicol 32(6 Suppl): 41S-64S
    › Primary publication · 24335967 (PubMed)
  16. Safety assessment of ammonium hectorites as used in cosmetics. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2013) Int J Toxicol 32(6 Suppl): 33S-40S
    › Primary publication · 24335966 (PubMed)
  17. Safety assessment of borosilicate glasses as used in cosmetics. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2013) Int J Toxicol 32(5 Suppl): 65S-72S
    › Primary publication · 24174476 (PubMed)
  18. Safety assessment of alkyl glyceryl ethers as used in cosmetics. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2013) Int J Toxicol 32(5 Suppl): 5S-21S
    › Primary publication · 24174475 (PubMed)
  19. Safety assessment of bis-diglyceryl polyacyladipate-2 and bis-diglyceryl polyacyladipate-1 as used in cosmetics. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2013) Int J Toxicol 32(5 Suppl): 56S-64S
    › Primary publication · 24174474 (PubMed)
  20. Safety assessment of lauriminodipropionic acid, sodium lauriminodipropionate, and disodium lauriminodipropionate as used in cosmetics. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2013) Int J Toxicol 32(5 Suppl): 49S-55S
    › Primary publication · 24174473 (PubMed)
  21. Safety assessment of decyl glucoside and other alkyl glucosides as used in cosmetics. Fiume MM, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2013) Int J Toxicol 32(5 Suppl): 22S-48S
    › Primary publication · 24174472 (PubMed)
  22. Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium. Ellis MJ, Gillette M, Carr SA, Paulovich AG, Smith RD, Rodland KK, Townsend RR, Kinsinger C, Mesri M, Rodriguez H, Liebler DC, Clinical Proteomic Tumor Analysis Consortium (CPTAC) (2013) Cancer Discov 3(10): 1108-12
    › Primary publication · 24124232 (PubMed) · PMC3800055 (PubMed Central)
  23. Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. Skates SJ, Gillette MA, LaBaer J, Carr SA, Anderson L, Liebler DC, Ransohoff D, Rifai N, Kondratovich M, Težak Ž, Mansfield E, Oberg AL, Wright I, Barnes G, Gail M, Mesri M, Kinsinger CR, Rodriguez H, Boja ES (2013) J Proteome Res 12(12): 5383-94
    › Primary publication · 24063748 (PubMed) · PMC4039197 (PubMed Central)
  24. Safety assessment of silylates and surface-modified siloxysilicates. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2013) Int J Toxicol 32(3 Suppl): 5S-24S
    › Primary publication · 23696579 (PubMed)
  25. Safety assessment of triethanolamine and triethanolamine-containing ingredients as used in cosmetics. Fiume MM, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2013) Int J Toxicol 32(3 Suppl): 59S-83S
    › Primary publication · 23696578 (PubMed)
  26. Safety assessment of diethanolamides as used in cosmetics. Fiume MM, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2013) Int J Toxicol 32(3 Suppl): 36S-58S
    › Primary publication · 23696577 (PubMed)
  27. Safety assessment of 2-amino-4-hydroxyethylaminoanisole and 2-amino-4-hydroxyethylaminoanisole sulfate as used in cosmetics. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2013) Int J Toxicol 32(3 Suppl): 25S-35S
    › Primary publication · 23696576 (PubMed)
  28. Targeted protein capture for analysis of electrophile-protein adducts. Connor RE, Codreanu SG, Marnett LJ, Liebler DC (2013) Methods Mol Biol : 163-76
    › Primary publication · 23475677 (PubMed) · PMC3801415 (PubMed Central)
  29. Safety assessment of alkyl benzoates as used in cosmetics. 'Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2012) Int J Toxicol 31(6 Suppl): 342S-72S
    › Primary publication · 23283706 (PubMed)
  30. Safety assessment of trimoniums as used in cosmetics. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2012) Int J Toxicol 31(6 Suppl): 296S-341S
    › Primary publication · 23283705 (PubMed)
  31. Safety assessment of isoparaffins as used in cosmetics. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2012) Int J Toxicol 31(6 Suppl): 269S-95S
    › Primary publication · 23283704 (PubMed)
  32. Safety assessment of propylene glycol, tripropylene glycol, and PPGs as used in cosmetics. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2012) Int J Toxicol 31(5 Suppl): 245S-60S
    › Primary publication · 23064775 (PubMed)
  33. Safety assessment of alkyl PEG ethers as used in cosmetics. Fiume MM, Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2012) Int J Toxicol 31(5 Suppl): 169S-244S
    › Primary publication · 23064774 (PubMed)
  34. Safety assessment of 1,2-glycols as used in cosmetics. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2012) Int J Toxicol 31(5 Suppl): 147S-68S
    › Primary publication · 23064773 (PubMed)
  35. Safety assessment of stearyl heptanoate and related stearyl alkanoates as used in cosmetics. Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2012) Int J Toxicol 31(5 Suppl): 141S-6S
    › Primary publication · 23064772 (PubMed)
  36. Final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of cocamidopropyl betaine (CAPB). Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2012) Int J Toxicol 31(4 Suppl): 77S-111S
    › Primary publication · 22869896 (PubMed)
  37. Final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of dicarboxylic acids, salts, and esters. Fiume MM, Heldreth B, Eldreth H, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2012) Int J Toxicol 31(4 Suppl): 5S-76S
    › Primary publication · 22869895 (PubMed)
  38. Final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of methyl acetate. Heldreth B, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2012) Int J Toxicol 31(4 Suppl): 112S-36S
    › Primary publication · 22869894 (PubMed)
  39. The development of selected reaction monitoring methods for targeted proteomics via empirical refinement. Bereman MS, MacLean B, Tomazela DM, Liebler DC, MacCoss MJ (2012) Proteomics 12(8): 1134-41
    › Primary publication · 22577014 (PubMed) · PMC3643124 (PubMed Central)
  40. A Reporter System for Translational Readthrough of Stop Codons in Human Cells. Halvey PJ, Liebler DC, Slebos RJ (2012) FEBS Open Bio : 56-59
    › Primary publication · 22563532 (PubMed) · PMC3342693 (PubMed Central)
  41. Label-free quantitation of protein modifications by pseudo selected reaction monitoring with internal reference peptides. Sherrod SD, Myers MV, Li M, Myers JS, Carpenter KL, Maclean B, Maccoss MJ, Liebler DC, Ham AJ (2012) J Proteome Res 11(6): 3467-79
    › Primary publication · 22559222 (PubMed) · PMC3368409 (PubMed Central)
  42. Precision of multiple reaction monitoring mass spectrometry analysis of formalin-fixed, paraffin-embedded tissue. Sprung RW, Martinez MA, Carpenter KL, Ham AJ, Washington MK, Arteaga CL, Sanders ME, Liebler DC (2012) J Proteome Res 11(6): 3498-505
    › Primary publication · 22530795 (PubMed) · PMC3368395 (PubMed Central)
  43. Global stability of plasma proteomes for mass spectrometry-based analyses. Zimmerman LJ, Li M, Yarbrough WG, Slebos RJ, Liebler DC (2012) Mol Cell Proteomics 11(6): M111.014340
    › Primary publication · 22301387 (PubMed) · PMC3433892 (PubMed Central)
  44. Safety assessment of xylene sulfonic acid, toluene sulfonic acid, and alkyl aryl sulfonate hydrotropes as used in cosmetics. Bergfeld WF, Belsito DV, Klaassen CD, Hill R, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2011) Int J Toxicol 30(6 Suppl): 270S-83S
    › Primary publication · 22247238 (PubMed)
  45. Final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of pelargonic acid (nonanoic acid) and nonanoate esters. Johnson W, Heldreth B, Bergfeld WF, Belsito DV, Klaassen CD, Hill R, Liebler D, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2011) Int J Toxicol 30(6 Suppl): 228S-69S
    › Primary publication · 22247237 (PubMed)
  46. Safety assessment of cyclomethicone, cyclotetrasiloxane, cyclopentasiloxane, cyclohexasiloxane, and cycloheptasiloxane. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2011) Int J Toxicol 30(6 Suppl): 149S-227S
    › Primary publication · 22247236 (PubMed)
  47. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, Tsukamoto T, Rojas CJ, Slusher BS, Zhang H, Zimmerman LJ, Liebler DC, Slebos RJ, Lorkiewicz PK, Higashi RM, Fan TW, Dang CV (2012) Cell Metab 15(1): 110-21
    › Primary publication · 22225880 (PubMed) · PMC3345194 (PubMed Central)
  48. Protein expression signatures for inhibition of epidermal growth factor receptor-mediated signaling. Myers MV, Manning HC, Coffey RJ, Liebler DC (2012) Mol Cell Proteomics 11(2): M111.015222
    › Primary publication · 22147731 (PubMed) · PMC3277773 (PubMed Central)
  49. Protein identification using customized protein sequence databases derived from RNA-Seq data. Wang X, Slebos RJ, Wang D, Halvey PJ, Tabb DL, Liebler DC, Zhang B (2012) J Proteome Res 11(2): 1009-17
    › Primary publication · 22103967 (PubMed) · PMC3727138 (PubMed Central)
  50. Proteomic consequences of a single gene mutation in a colorectal cancer model. Halvey PJ, Zhang B, Coffey RJ, Liebler DC, Slebos RJ (2012) J Proteome Res 11(2): 1184-95
    › Primary publication · 22103262 (PubMed) · PMC3271737 (PubMed Central)
  51. Final report of the Amended Safety Assessment of PVM/MA copolymer and its related salts and esters as used in cosmetics. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2011) Int J Toxicol 30(5 Suppl): 128S-44S
    › Primary publication · 22068629 (PubMed)
  52. Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells. Bose D, Zimmerman LJ, Pierobon M, Petricoin E, Tozzi F, Parikh A, Fan F, Dallas N, Xia L, Gaur P, Samuel S, Liebler DC, Ellis LM (2011) Br J Cancer 105(11): 1759-67
    › Primary publication · 22045189 (PubMed) · PMC3242606 (PubMed Central)
  53. Supporting tool suite for production proteomics. Ma ZQ, Tabb DL, Burden J, Chambers MC, Cox MB, Cantrell MJ, Ham AJ, Litton MD, Oreto MR, Schultz WC, Sobecki SM, Tsui TY, Wernke GR, Liebler DC (2011) Bioinformatics 27(22): 3214-5
    › Primary publication · 21965817 (PubMed) · PMC3208394 (PubMed Central)
  54. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P, Riising EM, Christensen LL, Thorsen K, Liebler DC, Helin K, Ørntoft TF, Andersen CL (2012) Oncogene 31(22): 2750-60
    › Primary publication · 21963845 (PubMed)
  55. Final report of the Cosmetic Ingredient Review Expert Panel safety assessment of polymethyl methacrylate (PMMA), methyl methacrylate crosspolymer, and methyl methacrylate/glycol dimethacrylate crosspolymer. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2011) Int J Toxicol 30(3 Suppl): 54S-65S
    › Primary publication · 21772027 (PubMed)
  56. Amended safety assessment of Sesamum indicum (sesame) seed oil, hydrogenated sesame seed oil, Sesamum indicum (sesame) oil unsaponifiables, and sodium sesameseedate. Johnson W, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2011) Int J Toxicol 30(3 Suppl): 40S-53S
    › Primary publication · 21772026 (PubMed)
  57. Painting a moving picture: large-scale proteomics efforts and their potential for changing patient care. Hoofnagle AN, Aebersold R, Anderson NL, Felsenfeld A, Liebler DC (2011) Clin Chem 57(10): 1357-60
    › Primary publication · 21540400 (PubMed)
  58. Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition. Rexer BN, Ham AJ, Rinehart C, Hill S, Granja-Ingram Nde M, González-Angulo AM, Mills GB, Dave B, Chang JC, Liebler DC, Arteaga CL (2011) Oncogene 30(40): 4163-74
    › Primary publication · 21499296 (PubMed) · PMC3204390 (PubMed Central)
  59. Mechlorethamine-induced DNA-protein cross-linking in human fibrosarcoma (HT1080) cells. Michaelson-Richie ED, Ming X, Codreanu SG, Loeber RL, Liebler DC, Campbell C, Tretyakova NY (2011) J Proteome Res 10(6): 2785-96
    › Primary publication · 21486066 (PubMed) · PMC3208907 (PubMed Central)
  60. A bioinformatics workflow for variant peptide detection in shotgun proteomics. Li J, Su Z, Ma ZQ, Slebos RJ, Halvey P, Tabb DL, Liebler DC, Pao W, Zhang B (2011) Mol Cell Proteomics 10(5): M110.006536
    › Primary publication · 21389108 (PubMed) · PMC3098595 (PubMed Central)
  61. Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry. Zhang H, Liu Q, Zimmerman LJ, Ham AJ, Slebos RJ, Rahman J, Kikuchi T, Massion PP, Carbone DP, Billheimer D, Liebler DC (2011) Mol Cell Proteomics 10(6): M110.006593
    › Primary publication · 21357624 (PubMed) · PMC3108838 (PubMed Central)
  62. Sequence tagging reveals unexpected modifications in toxicoproteomics. Dasari S, Chambers MC, Codreanu SG, Liebler DC, Collins BC, Pennington SR, Gallagher WM, Tabb DL (2011) Chem Res Toxicol 24(2): 204-16
    › Primary publication · 21214251 (PubMed) · PMC3042045 (PubMed Central)
  63. Amended safety assessment of dodecylbenzenesulfonate, decylbenzenesulfonate, and tridecylbenzenesulfonate salts as used in cosmetics. Becker LC, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2010) Int J Toxicol 29(6 Suppl): 288S-305
    › Primary publication · 21164075 (PubMed)
  64. Final amended safety assessment of hydroquinone as used in cosmetics. Andersen FA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW (2010) Int J Toxicol 29(6 Suppl): 274S-87
    › Primary publication · 21164074 (PubMed)
  65. Final report of the safety assessment of Kojic acid as used in cosmetics. Burnett CL, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA (2010) Int J Toxicol 29(6 Suppl): 244S-73
    › Primary publication · 21164073 (PubMed)
  66. Final report of the Cosmetic Ingredient Review Expert Panel amended safety assessment of Calendula officinalis-derived cosmetic ingredients. Andersen FA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW (2010) Int J Toxicol 29(6 Suppl): 221S-43
    › Primary publication · 21164072 (PubMed)
  67. DNA-protein cross-linking by 1,2,3,4-diepoxybutane. Michaelson-Richie ED, Loeber RL, Codreanu SG, Ming X, Liebler DC, Campbell C, Tretyakova NY (2010) J Proteome Res 9(9): 4356-67
    › Primary publication · 20666492 (PubMed) · PMC2956319 (PubMed Central)
  68. Final safety assessment of thiodipropionic acid and its dialkyl esters as used in cosmetics. Diamante C, Fiume MZ, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Alan Andersen F (2010) Int J Toxicol 29(4 Suppl): 137S-50S
    › Primary publication · 20634504 (PubMed)
  69. Use of dimedone-based chemical probes for sulfenic acid detection methods to visualize and identify labeled proteins. Nelson KJ, Klomsiri C, Codreanu SG, Soito L, Liebler DC, Rogers LC, Daniel LW, Poole LB (2010) Methods Enzymol : 95-115
    › Primary publication · 20513473 (PubMed) · PMC3835715 (PubMed Central)
  70. Efficacy of cetuximab in the treatment of Menetrier's disease. Fiske WH, Tanksley J, Nam KT, Goldenring JR, Slebos RJ, Liebler DC, Abtahi AM, La Fleur B, Ayers GD, Lind CD, Washington MK, Coffey RJ (2009) Sci Transl Med 1(8): 8ra18
    › Primary publication · 20368185 (PubMed) · PMC3638759 (PubMed Central)
  71. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, MacCoss MJ (2010) Bioinformatics 26(7): 966-8
    › Primary publication · 20147306 (PubMed) · PMC2844992 (PubMed Central)
  72. Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics. Rodriguez H, Tezak Z, Mesri M, Carr SA, Liebler DC, Fisher SJ, Tempst P, Hiltke T, Kessler LG, Kinsinger CR, Philip R, Ransohoff DF, Skates SJ, Regnier FE, Anderson NL, Mansfield E, Workshop Participants (2010) Clin Chem 56(2): 237-43
    › Primary publication · 20007859 (PubMed)
  73. Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration. Regnier FE, Skates SJ, Mesri M, Rodriguez H, Tezak Z, Kondratovich MV, Alterman MA, Levin JD, Roscoe D, Reilly E, Callaghan J, Kelm K, Brown D, Philip R, Carr SA, Liebler DC, Fisher SJ, Tempst P, Hiltke T, Kessler LG, Kinsinger CR, Ransohoff DF, Mansfield E, Anderson NL (2010) Clin Chem 56(2): 165-71
    › Primary publication · 20007858 (PubMed)
  74. Spin filter-based sample preparation for shotgun proteomics. Liebler DC, Ham AJ (2009) Nat Methods 6(11): 785; author reply 785-6
    › Primary publication · 19876013 (PubMed)
  75. Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance. Paulovich AG, Billheimer D, Ham AJ, Vega-Montoto L, Rudnick PA, Tabb DL, Wang P, Blackman RK, Bunk DM, Cardasis HL, Clauser KR, Kinsinger CR, Schilling B, Tegeler TJ, Variyath AM, Wang M, Whiteaker JR, Zimmerman LJ, Fenyo D, Carr SA, Fisher SJ, Gibson BW, Mesri M, Neubert TA, Regnier FE, Rodriguez H, Spiegelman C, Stein SE, Tempst P, Liebler DC (2010) Mol Cell Proteomics 9(2): 242-54
    › Primary publication · 19858499 (PubMed) · PMC2830837 (PubMed Central)
  76. Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses. Rudnick PA, Clauser KR, Kilpatrick LE, Tchekhovskoi DV, Neta P, Blonder N, Billheimer DD, Blackman RK, Bunk DM, Cardasis HL, Ham AJ, Jaffe JD, Kinsinger CR, Mesri M, Neubert TA, Schilling B, Tabb DL, Tegeler TJ, Vega-Montoto L, Variyath AM, Wang M, Wang P, Whiteaker JR, Zimmerman LJ, Carr SA, Fisher SJ, Gibson BW, Paulovich AG, Regnier FE, Rodriguez H, Spiegelman C, Tempst P, Liebler DC, Stein SE (2010) Mol Cell Proteomics 9(2): 225-41
    › Primary publication · 19837981 (PubMed) · PMC2830836 (PubMed Central)
  77. Network-assisted protein identification and data interpretation in shotgun proteomics. Li J, Zimmerman LJ, Park BH, Tabb DL, Liebler DC, Zhang B (2009) Mol Syst Biol : 303
    › Primary publication · 19690572 (PubMed) · PMC2736651 (PubMed Central)
  78. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AJ, Keshishian H, Hall SC, Allen S, Blackman RK, Borchers CH, Buck C, Cardasis HL, Cusack MP, Dodder NG, Gibson BW, Held JM, Hiltke T, Jackson A, Johansen EB, Kinsinger CR, Li J, Mesri M, Neubert TA, Niles RK, Pulsipher TC, Ransohoff D, Rodriguez H, Rudnick PA, Smith D, Tabb DL, Tegeler TJ, Variyath AM, Vega-Montoto LJ, Wahlander A, Waldemarson S, Wang M, Whiteaker JR, Zhao L, Anderson NL, Fisher SJ, Liebler DC, Paulovich AG, Regnier FE, Tempst P, Carr SA (2009) Nat Biotechnol 27(7): 633-41
    › Primary publication · 19561596 (PubMed) · PMC2855883 (PubMed Central)
  79. Reversibility of covalent electrophile-protein adducts and chemical toxicity. Lin D, Saleh S, Liebler DC (2008) Chem Res Toxicol 21(12): 2361-9
    › Primary publication · 19548357 (PubMed) · PMC2772158 (PubMed Central)
  80. Proteomic analysis of DNA-protein cross-linking by antitumor nitrogen mustards. Loeber RL, Michaelson-Richie ED, Codreanu SG, Liebler DC, Campbell CR, Tretyakova NY (2009) Chem Res Toxicol 22(6): 1151-62
    › Primary publication · 19480393 (PubMed) · PMC2706101 (PubMed Central)
  81. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis. Sprung RW, Brock JW, Tanksley JP, Li M, Washington MK, Slebos RJ, Liebler DC (2009) Mol Cell Proteomics 8(8): 1988-98
    › Primary publication · 19467989 (PubMed) · PMC2722776 (PubMed Central)
  82. Global analysis of protein damage by the lipid electrophile 4-hydroxy-2-nonenal. Codreanu SG, Zhang B, Sobecki SM, Billheimer DD, Liebler DC (2009) Mol Cell Proteomics 8(4): 670-80
    › Primary publication · 19054759 (PubMed) · PMC2667350 (PubMed Central)
  83. Evaluation of strong cation exchange versus isoelectric focusing of peptides for multidimensional liquid chromatography-tandem mass spectrometry. Slebos RJ, Brock JW, Winters NF, Stuart SR, Martinez MA, Li M, Chambers MC, Zimmerman LJ, Ham AJ, Tabb DL, Liebler DC (2008) J Proteome Res 7(12): 5286-94
    › Primary publication · 18939861 (PubMed) · PMC2669493 (PubMed Central)
  84. Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor. Parastatidis I, Thomson L, Burke A, Chernysh I, Nagaswami C, Visser J, Stamer S, Liebler DC, Koliakos G, Heijnen HF, Fitzgerald GA, Weisel JW, Ischiropoulos H (2008) J Biol Chem 283(49): 33846-53
    › Primary publication · 18818200 (PubMed) · PMC2590685 (PubMed Central)
  85. Identification of proteins adducted by lipid peroxidation products in plasma and modifications of apolipoprotein A1 with a novel biotinylated phospholipid probe. Szapacs ME, Kim HY, Porter NA, Liebler DC (2008) J Proteome Res 7(10): 4237-46
    › Primary publication · 18778096 (PubMed) · PMC2664612 (PubMed Central)
  86. Mitochondrial protein targets of thiol-reactive electrophiles. Wong HL, Liebler DC (2008) Chem Res Toxicol 21(4): 796-804
    › Primary publication · 18324786 (PubMed) · PMC3805131 (PubMed Central)
  87. Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3. Rachakonda G, Xiong Y, Sekhar KR, Stamer SL, Liebler DC, Freeman ML (2008) Chem Res Toxicol 21(3): 705-10
    › Primary publication · 18251510 (PubMed)
  88. Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives. Vila A, Tallman KA, Jacobs AT, Liebler DC, Porter NA, Marnett LJ (2008) Chem Res Toxicol 21(2): 432-44
    › Primary publication · 18232660 (PubMed) · PMC2760080 (PubMed Central)
  89. Protein damage by reactive electrophiles: targets and consequences. Liebler DC (2008) Chem Res Toxicol 21(1): 117-28
    › Primary publication · 18052106 (PubMed) · PMC2533766 (PubMed Central)
  90. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. Yildiz PB, Shyr Y, Rahman JS, Wardwell NR, Zimmerman LJ, Shakhtour B, Gray WH, Chen S, Li M, Roder H, Liebler DC, Bigbee WL, Siegfried JM, Weissfeld JL, Gonzalez AL, Ninan M, Johnson DH, Carbone DP, Caprioli RM, Massion PP (2007) J Thorac Oncol 2(10): 893-901
    › Primary publication · 17909350 (PubMed) · PMC4220686 (PubMed Central)
  91. Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I deficient mice. Parastatidis I, Thomson L, Fries DM, Moore RE, Tohyama J, Fu X, Hazen SL, Heijnen HF, Dennehy MK, Liebler DC, Rader DJ, Ischiropoulos H (2007) Circ Res 101(4): 368-76
    › Primary publication · 17615369 (PubMed)
  92. Protein targets of reactive electrophiles in human liver microsomes. Shin NY, Liu Q, Stamer SL, Liebler DC (2007) Chem Res Toxicol 20(6): 859-67
    › Primary publication · 17480101 (PubMed) · PMC2556149 (PubMed Central)
  93. Analysis of protein adduction kinetics by quantitative mass spectrometry: competing adduction reactions of glutathione-S-transferase P1-1 with electrophiles. Orton CR, Liebler DC (2007) Chem Biol Interact 168(2): 117-27
    › Primary publication · 17433278 (PubMed) · PMC2063493 (PubMed Central)
  94. Proteomics of lipid oxidation-induced oxidation of porcine and bovine oxymyoglobins. Suman SP, Faustman C, Stamer SL, Liebler DC (2007) Proteomics 7(4): 628-40
    › Primary publication · 17309108 (PubMed)
  95. Phospholipid-protein adducts of lipid peroxidation: synthesis and study of new biotinylated phosphatidylcholines. Tallman KA, Kim HY, Ji JX, Szapacs ME, Yin H, McIntosh TJ, Liebler DC, Porter NA (2007) Chem Res Toxicol 20(2): 227-34
    › Primary publication · 17305406 (PubMed)
  96. Covalent adduction of human serum albumin by 4-hydroxy-2-nonenal: kinetic analysis of competing alkylation reactions. Szapacs ME, Riggins JN, Zimmerman LJ, Liebler DC (2006) Biochemistry 45(35): 10521-8
    › Primary publication · 16939204 (PubMed)
  97. Inhibition of protein phosphatase 2A activity by selective electrophile alkylation damage. Codreanu SG, Adams DG, Dawson ES, Wadzinski BE, Liebler DC (2006) Biochemistry 45(33): 10020-9
    › Primary publication · 16906760 (PubMed)
  98. Selectively increased oxidative modifications mapped to detergent-insoluble forms of Abeta and beta-III tubulin in Alzheimer's disease. Boutte AM, Woltjer RL, Zimmerman LJ, Stamer SL, Montine KS, Manno MV, Cimino PJ, Liebler DC, Montine TJ (2006) FASEB J 20(9): 1473-83
    › Primary publication · 16816122 (PubMed)
  99. N-Terminal amino acid side-chain cleavage of chemically modified peptides in the gas phase: a mass spectrometry technique for N-terminus identification. Chacon A, Masterson DS, Yin H, Liebler DC, Porter NA (2006) Bioorg Med Chem 14(18): 6213-22
    › Primary publication · 16784867 (PubMed)
  100. The poisons within: application of toxicity mechanisms to fundamental disease processes. Liebler DC (2006) Chem Res Toxicol 19(5): 610-3
    › Primary publication · 16696562 (PubMed)
  101. Identification of S-nitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cells. Greco TM, Hodara R, Parastatidis I, Heijnen HF, Dennehy MK, Liebler DC, Ischiropoulos H (2006) Proc Natl Acad Sci U S A 103(19): 7420-5
    › Primary publication · 16648260 (PubMed) · PMC1464354 (PubMed Central)
  102. Redox instability induced by 4-hydroxy-2-nonenal in porcine and bovine myoglobins at pH 5.6 and 4 degrees C. Suman SP, Faustman C, Stamer SL, Liebler DC (2006) J Agric Food Chem 54(9): 3402-8
    › Primary publication · 16637701 (PubMed)
  103. Identification of phosphorylation sites in glycine N-methyltransferase from rat liver. Luka Z, Ham AJ, Norris JL, Yeo EJ, Yermalitsky V, Glenn B, Caprioli RM, Liebler DC, Wagner C (2006) Protein Sci 15(4): 785-94
    › Primary publication · 16522797 (PubMed) · PMC2242492 (PubMed Central)
  104. Proteomics: clinical applications for head and neck squamous cell carcinoma. Yarbrough WG, Slebos RJ, Liebler D (2006) Head Neck 28(6): 549-58
    › Primary publication · 16475197 (PubMed)
  105. Cytosolic and nuclear protein targets of thiol-reactive electrophiles. Dennehy MK, Richards KA, Wernke GR, Shyr Y, Liebler DC (2006) Chem Res Toxicol 19(1): 20-9
    › Primary publication · 16411652 (PubMed)
  106. Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Hong F, Freeman ML, Liebler DC (2005) Chem Res Toxicol 18(12): 1917-26
    › Primary publication · 16359182 (PubMed)
  107. Identification of protein fragments as pattern features in MALDI-MS analyses of serum. Zimmerman LJ, Wernke GR, Caprioli RM, Liebler DC (2005) J Proteome Res 4(5): 1672-80
    › Primary publication · 16212420 (PubMed)
  108. Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. Hong F, Sekhar KR, Freeman ML, Liebler DC (2005) J Biol Chem 280(36): 31768-75
    › Primary publication · 15985429 (PubMed)
  109. Elucidating mechanisms of drug-induced toxicity. Liebler DC, Guengerich FP (2005) Nat Rev Drug Discov 4(5): 410-20
    › Primary publication · 15864270 (PubMed)
  110. Proteomic identification of ubiquitinated proteins from human cells expressing His-tagged ubiquitin. Kirkpatrick DS, Weldon SF, Tsaprailis G, Liebler DC, Gandolfi AJ (2005) Proteomics 5(8): 2104-11
    › Primary publication · 15852347 (PubMed)
  111. P-Mod: an algorithm and software to map modifications to peptide sequences using tandem MS data. Hansen BT, Davey SW, Ham AJ, Liebler DC (2005) J Proteome Res 4(2): 358-68
    › Primary publication · 15822911 (PubMed)
  112. Shotgun mass spec goes independent. Liebler DC (2004) Nat Methods 1(1): 16-7
    › Primary publication · 15782148 (PubMed)
  113. Sample preparation and digestion for proteomic analyses using spin filters. Manza LL, Stamer SL, Ham AJ, Codreanu SG, Liebler DC (2005) Proteomics 5(7): 1742-5
    › Primary publication · 15761957 (PubMed)